Search

The results of immunocytochemical studies using two different monoclonal antibodies against the M1 subunit of ribonucleotide reductase show an exclusively cytoplasmic localization of this subunit both in cultured MDBK and mouse 3T6 cells, and in cells from various rat tissues. By fluorescent light microscopy, there is a diffuse staining of the cytoplasm, while by electron microscopy the immunoreactive material appears to be associated with ribosomes. In the rat tissues, only actively dividing cells show M1‐specific immunofluorescence revealing a strong correlation between the presence of protein M1 and DNA synthesis. Therefore M1 immunofluorescence could be used to study cell proliferation in normal, inflammatory or neoplastic tissue. A lesser variation in M1 staining is observed between individual cells in tissue culture, where most cells are positive, but neither here nor in the tissues examined are any cells with nuclear staining detected. We interpret our results to mean that in mammalian cells ribonucleotide reduction takes place in the cytoplasm and from there the deoxyribonucleotides are transported into the nucleus to serve in DNA synthesis.

Ribonucleotide reductase (RR) activity in mammalian cells is closely linked to DNA synthesis. The RR enzyme is composed of two non‐identical subunits, proteins R1 and R2. Both proteins are required for holoenzyme activity, which is regulated by S‐phase specific de novo synthesis and breakdown of the R2 subunit. In quiescent cells stimulated to proliferate and in elutriated cell populations enriched in the various cell cycle phases the R2 protein levels are correlated to R2 mRNA levels that are low in G0/G1‐phase cells but increase dramatically at the G1/S border. Using an R2 promoter‐luciferase reporter gene construct we demonstrate an unexpected early activation of the R2 promoter as cells pass from quiescence to proliferation. However, due to a transcriptional block, this promoter activation only results in very short R2 transcripts until cells enter the S‐phase, when full‐length R2 transcripts start to appear. The position for the transcriptional block was localized to a nucleotide sequence approximately 87 bp downstream from the first exon/intron boundary by S1 nuclease mapping of R2 transcripts from modified in vitro nuclear run‐on experiments. These results identify blocking of transcription as a mechanism to control cell cycle regulated gene expression.

Mammalian ribonucleotide reductase consists of two non‐identical subunits, proteins M1 and M2. M2‐related DNA sequences are present on mouse chromosomes 4, 7, 12 and 13. However, M2‐overproducing mouse cells show amplification of a chromosome 12‐specific, single 13 kb HindIII fragment, which probably represents the active gene. We have isolated this fragment from parental mouse cell DNA and used it to clone and characterize the functional M2 gene. The 5770 bp transcribed M2 sequence contains ten exons separated by nine 95‐917 bp introns. The 501 bp of 5′ flanking DNA is G + C rich and contains TTTAAA and CCAAT sequences as well as potential Sp1 binding sites. The M2‐related sequence on chromosome 13, which contains only the last six exons and several internal rearrangements, is a pseudogene. Transfection of BALB/3T3 cells with the M2 gene resulted in stable transformants with a 10‐fold reduction in sensitivity to hydroxyurea, compared to control cells. This confirmed that the cloned M2 genomic DNA represents the functional gene and conclusively establishes the link between hydroxyurea resistance and M2 expression in mammalian cells. M2 genomic DNA should be a valuable dominant, selectable marker for identifying and isolating stable co‐transformants.